- Home
- NTHI vs SSSS Comparison
NTHI vs SSSS Comparison
Compare NTHI & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- SSSS
- Stock Information
- Founded
- NTHI 2008
- SSSS 2010
- Country
- NTHI United States
- SSSS United States
- Employees
- NTHI N/A
- SSSS N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- SSSS Finance: Consumer Services
- Sector
- NTHI Health Care
- SSSS Finance
- Exchange
- NTHI Nasdaq
- SSSS Nasdaq
- Market Cap
- NTHI 142.5M
- SSSS 138.2M
- IPO Year
- NTHI N/A
- SSSS N/A
- Fundamental
- Price
- NTHI $4.26
- SSSS $7.34
- Analyst Decision
- NTHI
- SSSS Buy
- Analyst Count
- NTHI 0
- SSSS 2
- Target Price
- NTHI N/A
- SSSS $8.00
- AVG Volume (30 Days)
- NTHI 23.3K
- SSSS 291.2K
- Earning Date
- NTHI 01-01-0001
- SSSS 08-06-2025
- Dividend Yield
- NTHI N/A
- SSSS N/A
- EPS Growth
- NTHI N/A
- SSSS N/A
- EPS
- NTHI N/A
- SSSS N/A
- Revenue
- NTHI $79,990.00
- SSSS $3,644,430.00
- Revenue This Year
- NTHI N/A
- SSSS $5,400.03
- Revenue Next Year
- NTHI N/A
- SSSS N/A
- P/E Ratio
- NTHI N/A
- SSSS N/A
- Revenue Growth
- NTHI 13.52
- SSSS N/A
- 52 Week Low
- NTHI $4.11
- SSSS $3.52
- 52 Week High
- NTHI $25.00
- SSSS $7.83
- Technical
- Relative Strength Index (RSI)
- NTHI N/A
- SSSS 66.84
- Support Level
- NTHI N/A
- SSSS $7.11
- Resistance Level
- NTHI N/A
- SSSS $7.50
- Average True Range (ATR)
- NTHI 0.00
- SSSS 0.34
- MACD
- NTHI 0.00
- SSSS -0.04
- Stochastic Oscillator
- NTHI 0.00
- SSSS 69.38
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.